Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AVADEL PHARMACEUTICALS PLC | Director | Ordinary Shares | 11K | $112K | $10.19 | Jul 30, 2024 | Direct |
Bellerophon Therapeutics, Inc. | Director | Common Stock | 292K | $30.3K | $0.10 | Jun 7, 2023 | Direct |
AVADEL PHARMACEUTICALS PLC | Director | Stock Option (Right to Buy) | 11K | Jul 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVDL | AVADEL PHARMACEUTICALS PLC | Jul 30, 2024 | 2 | $0 | 4 | Aug 1, 2024 | Director |
AVDL | AVADEL PHARMACEUTICALS PLC | May 17, 2024 | 1 | $0 | 4 | May 21, 2024 | Director |
AVDL | AVADEL PHARMACEUTICALS PLC | May 17, 2024 | 0 | $0 | 3 | May 21, 2024 | Director |
BLPH | Bellerophon Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
BLPH | Bellerophon Therapeutics, Inc. | Feb 10, 2023 | 1 | $0 | 4 | Feb 14, 2023 | Director |
BLPH | Bellerophon Therapeutics, Inc. | Dec 31, 2021 | 2 | $26.9K | 4 | Jan 4, 2022 | Director |